Document Detail


Management of infantile polyposis syndrome.
MedLine Citation:
PMID:  7492168     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A boy with generalised infantile polyposis syndrome is reported to highlight the difficulties in management. Despite attempts to reduce polyp mass by regular endoscopic polypectomy, daily transfusions of blood products, and a trial of the non-steroidal anti-inflammatory agent sulindac, his condition gradually deteriorated and he died of septicaemia.
Authors:
G J Stiff; A Alwafi; H Jenkins; J Lari
Related Documents :
4338368 - Amotivational syndrome: the real management problem of schizophrenia.
20609798 - Off-pump coronary artery bypass grafting in a patient with bernard-soulier syndrome.
69318 - Kepone-induced scoliosis and its histological consequences in fish.
18534698 - Tako-tsubo syndrome following a difficult urinary catheterization.
5662548 - Syndrome with joint manifestations in association with mycoplasma pneumoniae infection.
8548938 - A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of cushing's...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Archives of disease in childhood     Volume:  73     ISSN:  1468-2044     ISO Abbreviation:  Arch. Dis. Child.     Publication Date:  1995 Sep 
Date Detail:
Created Date:  1996-01-02     Completed Date:  1996-01-02     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  0372434     Medline TA:  Arch Dis Child     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  253-4     Citation Subset:  AIM; IM    
Affiliation:
Department of Paediatric Surgery, University Hospital of Wales, Cardiff.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Blood Component Transfusion
Colonic Polyps / therapy*
Endoscopy
Fatal Outcome
Humans
Infant
Male
Sepsis / etiology
Sulindac / therapeutic use
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents, Non-Steroidal; 38194-50-2/Sulindac
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Growth hormone deficiency and empty sella in DIDMOAD syndrome: an endocrine study.
Next Document:  Osteopenia in Crohn's disease.